Colgate-Palmolive Company $CL Stock Holdings Decreased by Parallel Advisors LLC

Parallel Advisors LLC lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 7.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 79,916 shares of the company’s stock after selling 6,477 shares during the quarter. Parallel Advisors LLC’s holdings in Colgate-Palmolive were worth $6,389,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Meiji Yasuda Life Insurance Co grew its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Meiji Yasuda Life Insurance Co now owns 21,157 shares of the company’s stock worth $1,691,000 after purchasing an additional 3,975 shares in the last quarter. Meiji Yasuda Asset Management Co Ltd. grew its holdings in shares of Colgate-Palmolive by 42.4% during the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 124,379 shares of the company’s stock valued at $9,943,000 after buying an additional 37,056 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC raised its position in Colgate-Palmolive by 217.0% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock valued at $3,246,000 after buying an additional 27,796 shares during the period. First Trust Advisors LP lifted its stake in Colgate-Palmolive by 7.3% in the 3rd quarter. First Trust Advisors LP now owns 2,727,297 shares of the company’s stock worth $218,020,000 after acquiring an additional 186,504 shares in the last quarter. Finally, Intellectus Partners LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $618,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $93.55 on Monday. The firm has a market cap of $75.41 billion, a price-to-earnings ratio of 35.71, a price-to-earnings-growth ratio of 4.22 and a beta of 0.28. The company’s fifty day moving average is $88.98 and its 200-day moving average is $83.03. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the business earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Insider Buying and Selling

In related news, insider Sally Massey sold 15,851 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the sale, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. The trade was a 53.55% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the transaction, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 in the last quarter. Company insiders own 0.41% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CL shares. Evercore upped their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Piper Sandler boosted their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. TD Cowen reiterated a “buy” rating on shares of Colgate-Palmolive in a research note on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research note on Friday, February 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.